Your SlideShare is downloading. ×
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

SVX: Unlocking the capital markets for healthcare companies - MaRS Future of Medicine™

723

Published on

Are you a health-science entrepreneur currently raising capital or planning to raise capital in the coming months? …

Are you a health-science entrepreneur currently raising capital or planning to raise capital in the coming months?

The SVX is a private investment platform built to connect impact ventures, funds and investors. Its aim is to catalyze new debt and equity investment capital for ventures that have demonstrable social or environmental impact and the potential for financial return.

The SVX will present its platform and discuss the potential for healthcare companies to use the SVX to reach new sources of debt and equity capital.

Published in: Business, Economy & Finance
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
723
On Slideshare
0
From Embeds
0
Number of Embeds
8
Actions
Shares
0
Downloads
7
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Future&of&Medicine:& Unlocking)the)Capital)Markets)for)Healthcare)Companies) October)31,)2013) Contact:(Carlos)Pinto)Lobo:)cpintolobo@marsdd.com)
  • 2. 1"
  • 3. 3"
  • 4. Problem& There)is)growing)group)of)social)entrepreneurs)and)impact)investors,)but...)   Ventures&lack&access&to&capital:&70%"of" impact"ventures"report"that"access"to" capital"is"a"major"challenge"to"their" success."   Raising&capital&is&costly:&It"can"cost"tens" to"hundreds"of"thousands"of"dollars"for" impact"ventures"to"raise"capital.""   Due&diligence&is&costly&and&9me& consuming:&It"can"be"costly"and"?me" consuming"for"investors"to"conduct"due" diligence."   There&is&an&uncoordinated&impact& inves9ng&marketplace:&No"access"point" to"find"investment"opportuni?es"or" connect"with"investors." Pg."3"
  • 5. Solu9on& The)first)plaHorm)of)its)kind)in)the)world)   SVX&is"registered"as"a"restricted"dealer" with"the"Ontario"Securi?es"Commission."   Access:&We"are"a"single"point"of"access"to" a"diverse"range"of"impact"investment" opportuni?es""   Cost&effec9ve:&Our"services"are"available" at"very"low"or"no"cost;"thereby"reducing" transac?on"and"opera?on"costs."   An&independent,&values&driven,&nonF profit&organiza9on:&SVX"is"commiKed"to" suppor?ng"and"enabling"the"growth"of" impact"inves?ng"to"benefit"social," environmental"and"economic" development." Pg."4"
  • 6. Solu9on& A)single)access)point)for)impact)ventures)and)investors) +" Impact Investing Pg."5"
  • 7. Target Issuers Who are the target ventures and funds? Impact ventures and funds (<$25M revenues) including nonprofits (including charities), cooperatives (nonprofits and for-profits), and for-profit businesses looking for $25k - $10M. Pg."6" "
  • 8. Target Issuers Who are the target ventures and funds? Pg."7"
  • 9. Target&Investors& Who)are)the)target)investors)for)SVX?)   Accredited&investors&as"defined"under" the"Ontario"Securi?es"Commission" (OSC)"regula?ons"(or"the"equivalent"in" other"jurisdic?ons)."   Investors"will"include"founda9ons&and& endowments&(private,&public,&or& community),&asset&managers,&wealth& advisors,&and&high&net&worth& individuals"that"meet"the"defini?onal" requirements"of"an"accredited"investor" as"per"securi?es"regula?ons."   Pa9ent,&impactFfirst&investors&with"a" focus"on"achieving"posi?ve"social"and/ or"environmental"outcomes"and" modest"to"market"financial"returns" Pg."8"
  • 10. Investor&Challenges& What)challenges)do)investors)face?)   Lack&of&deal&flow:&Given"limited"resources," impact"investors"cannot"easily"iden?fy"quality" impact"investments"in"order"to"make"an" appropriate"investment." "   Lack&of&exper9se:&Impact"investors"do"not" always"have"the"ability"to"prepare"and"conduct" due"diligence." & •  There&is&a&tremendous&opportunity&in&the& growing&marketplace:&Currently"the"total" Canadian"impact"investment"market"is"$5.3" billion"and"is"expected"to"grow"to"$30"billion"in" 10"years.""" Pg."9"
  • 11. Features&&&Benefits& How)does)SVX)work?) Pg."10"
  • 12. Target&Issuers& What)are)the)requirements)for)ventures)and)funds?) PLATFORM&ACCESS&REQUIREMENT&SUMMARY& Governance&&&Management& •  •  •  •  " Ontario"incorporated" Strong"governance"structure" Evidence"of"relevant"exper?se"within" management"and/or"directors" Disclosure"of"any"current"or"past"legal"ac?ons" against"management"and/or"directors" Impact& " Ontario[focused"impact" Five"(5)"Key"Performance"Indicators"(IRIS[ based"if"possible)" •  GIIRS,"3rd"party"ra?ng"(or"B"Corp),"for"social" purpose"businesses" •  Impact"narra?ve" •  •  Financials& " Revenue[genera?ng"($50k"["$25M"annually)" Audited"or"reviewed"financial"statements" Pro[forma"projec?ons" Adequate"current"assets,"fixed"assets,"or"cash" reserves" •  Ownership"informa?on,"including"past"and" current"sources"of"capital"" •  •  •  •  Other& " Complete"business"plan" External,"professional"references" Auditor/reviewer"&"legal"counsel"contact" informa?on" •  Debt"&/or"equity"capital"need"($25k[10M"for" ventures,"$2[50M+"for"funds)" •  IP"&"R&D"informa?on"(if"necessary"should" venture"not"meet"revenue"requirements)" •  •  •  Pg."11"
  • 13. Measuring&Impact& How)do)we)measure)impact?) “A(standard(with(a(ra1ng(system(can(help(hold(the(line(on(social(impact(and( differen1ate(those(who(are(truly(making(a(difference(from(those(who(are(simply( telling(a(story."& Antony)BuggRLevine,)Author,)Impact)InvesTng)&)CEO,)Nonprofit)Finance)Fund)(NFF)" Ra9ngs:&For[profit"organiza?ons"are"required"to" complete"either"a"Global"Impact"Inves?ng" Ra?ngs"and"aKain"a"score"of"100,or"be"a"B"Corp.& " Metrics:&Each"issuer"is"required"to"submit"5"key" metrics." & Narra9ve:&All"issuers"must"have"an"impact" narra?ve,"which"explains"the"impact"they"are" hoping"to"achieve." & Pg."12"
  • 14. Third&Party&Ra9ngs&Providers& Global)Impact)InvesTng)RaTngs)System) " " GIIRS"offers"a"company"seeking"investment"capital"a"ra?ng"of"its" social"and"environmental"impact"including:"" " 1.  an"overall"ra?ng;"" 2.  ra?ngs"in"approximately"15"sub[categories;"" 3.  key"performance"indicators"(KPI's)"relevant"to"the"company's" industry,"geography,"size,"and"social"mission;"and"benchmark"data" highligh?ng"a"company's"performance"as"compared"to"its"peers." Pg."13"
  • 15. Third&Party&Ra9ngs&Providers& B)Corps)(Benefit)CorporaTons)) •  B Corp is a third-party certification for companies using the power of business to solve social or environmental problems. •  Certified B Corps are committed to the idea of holistic success that takes into account community investment, environmental impact and workplace experience. They are committed to the “big idea” of using business as a force for good and they’re willing to have an outside group measure their effort & publish the results for all the world to see. " Pg."14"
  • 16. Becoming&a&B&Corps& 1.  Take"the"B"Impact"Assessment"       1"–"3"hours"of"ini?al"self"assessment" Be"prepared"by"having"all"your"financials"and"business"sta?s?cs"available"to"speed"the" process" At"the"end"of"the"assessment"you"will"be"provided"a"B"Impact"ra?ng" 2.  Complete"an"Assessment"Review"   A"B"Labs"staff"member"will"call"and"go"through"the"ques?onnaire"with"you"and"provide" you"an"assessment"of"what"your"ra?ng"truly"is." 3.  Submit"Suppor?ng"Documenta?on"   The"Assessment"will"randomly"select"8"–"12"ques?ons"answered"in"the"affirma?ve"and" will"ask"for"further"details"that"demonstrate"those"prac?ces." 4.  Complete"Disclosure"Ques?onnaire"   Your"company"must"disclose"any"sensi?ve"prac?ces,"fines"and"sanc?ons"related"to"the" company"or"its"partners." Pg."15"
  • 17. Investor"Search"Screen" Pg."16"
  • 18. Pg."17"
  • 19. Pg."18"
  • 20. Team& Who)is)behind)the)SVX?) Adam&Spence& Founder)&)UDP) Social"entrepreneur"with"10+" years"senior"leadership" experience." Carlos&Pinto&Lobo& Chief)Compliance)Officer) 25+"years"senior"leadership" experience"in"compliance"in" mainstream"finance." Tris9na&Sinopoli& Project)Coordinator) York"University"business"grad" with"experience"in"local" government."" Pg."19"
  • 21. Team& Who)is)behind)the)SVX?) Board&of&Directors&  Dr.&Ilse&Treurnicht,&CEO,"MaRS"  Ted&Anderson,&Director,"MaRS"Centre"for" Impact"Inves?ng"  Grace&Lee&Reynolds,&VP"Finance,"MaRS" & Advisors&   Kevin&Doyle,"Director,"TMX"Group"Inc."   Aaron&Emes,"Partner,"Torys"LLP"   Catherine&De&Gius9,&Associate,"Torys"LLP"   Allyson&Hewi,"Director,"MaRS"   Marc&Marzoo,"Associate,"Gryphon"Investment" Counsel"   Don&McCreesh,"Former"Chair,"Imagine"Canada"   Robert&Peterman,"Director,"TMX"Group"Inc."   Cynthia&Peters,"Owner,"From"the"Farm"Enterprises"   Nelson&Switzer,"Director,"PwC"   Alberta&Leung,"Partner,"KPMG" STRATEGIC&PARTNERS& Legal&Counsel& Pla]orm&Development& Background&Checks& Third&Party&Impact&Assessment& Pg."20"
  • 22. Next&Steps& What)is)next)for)the)SVX)plaHorm?)   Outreach&and&Pipeline&Building.&We" are"con?nuing"to"build"our"pipeline"of" ventures,"funds,"investors"and"service" providers."   Public&Launch.&We"launched"the"SVX" at"the"TMX"on"September"19th,"and" since"then"12"ventures"have"placed" their"offering"on"the"SVX"with"more"in" the"background"   Franchising.&We"are"pursuing" opportuni?es"to"franchise"the" plaporm"in"Canada,"US,"and"around" the"world,"and"exploring"leveraging" the"plaporm"for"other"formats," including"crowdfunding." Pg."21"
  • 23. Resources& SVX:&hp://www.svx.ca& MaRS&Discovery&District:&hp://www.marsdd.com& GIIRS:&hp://giirs.org& B&Corps:&hp://www.bcorpora9on.net& IRIS:&hp://iris.thegiin.org& SocialFinance.ca:&www.socialfinance.ca& & & Pg."22"
  • 24. Thank&You& Carlos&Pinto&Lobo& Chief"Compliance"Officer,"SVX" Carlos.pintolobo@svx.ca" cpintolobo@marsdd.com" " Pg."23"

×